Evidence map›Paper›PMID 37328694›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2023

Ascending aorta dilatation is associated to hard cardiovascular events, follow-up from multicentric ARGO-Perspective project.

Lorenzo Airale, Francesco Borrelli, Alessio Arrivi, Alessandro Baracchi, Fabio Bertacchini, Iside Cartella, Rosa Curcio, Raffaele Izzo, Maria Lembo, Costantino Mancusi and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Aortic dilatation and cardiovascular events: a new piece of the puzzle?Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Lorenzo AiraleDepartment of Medical Sciences, Hypertension Center-University of Torino-AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Francesco BorrelliDepartment of Medical Sciences, Hypertension Center-University of Torino-AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Alessio ArriviSC Medicina Interna, Azienda Ospedaliero-Universitaria di Terni, Terni, Italy.
Alessandro BaracchiCardiothoracic and Vascular Department, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Fabio BertacchiniDepartment of Internal Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
Iside CartellaEcho Lab, Cardiologia IV, De Gasperis Department, ASST Niguarda Ca Granda e Dip Medicina e Chirurgia, Università Milano Bicocca, Milano, Italy.
Rosa CurcioSC Medicina Interna, Azienda Ospedaliero-Universitaria di Terni, Terni, Italy.
Raffaele IzzoHypertension Research Center, Federico II University Hospital, Napoli, Italy.
Maria LemboHypertension Research Center, Federico II University Hospital, Napoli, Italy.
Costantino MancusiHypertension Research Center, Federico II University Hospital, Napoli, Italy.
Maria Virgina ManziHypertension Research Center, Federico II University Hospital, Napoli, Italy.
Martina MilaniEcho Lab, Cardiologia IV, De Gasperis Department, ASST Niguarda Ca Granda e Dip Medicina e Chirurgia, Università Milano Bicocca, Milano, Italy.
Antonella MoreoEcho Lab, Cardiologia IV, De Gasperis Department, ASST Niguarda Ca Granda e Dip Medicina e Chirurgia, Università Milano Bicocca, Milano, Italy.
Anna PainiDepartment of Internal Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
Giacomo PucciSC Medicina Interna, Azienda Ospedaliero-Universitaria di Terni, Terni, Italy.
Federico RuscelliCardiothoracic and Vascular Department, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Massimo SalvettiDepartment of Internal Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
Mario SoldatiCardiothoracic and Vascular Department, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Alberto MilanDepartment of Medical Sciences, Hypertension Center-University of Torino-AOU Città della Salute e della Scienza di Torino, Torino, Italy. alberto.milan@unito.it.
Federico II University Hospital · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aortic root dilatation has been proposed as hypertension-mediated organ damage (HMOD). Nevertheless, the role of the aortic root dilatation as a possible additional HMOD is still unclear since studies conducted so far are quite heterogeneous regarding the type of population analyzed, the aortic tract considered, and the type of outcomes accounted for. The aim of the present study is to assess whether the presence of aortic dilatation is associated with strong cardiovascular (CV) events (MACE: heart failure, CV death, stroke, acute coronary syndrome, myocardial revascularization) in a population of patients affected by essential hypertension. Four hundred forty-five hypertensive patients from six Italian hospitals were recruited as part of ARGO-SIIA study1. For all centers, follow-up was obtained by re-contacting all patients by telephone and through the hospital's computer system. Aortic dilatation (AAD) was defined through absolute sex-specific thresholds as in previous studies (41 mm for males, 36 mm for females). Median follow-up was 60 months. AAD was found to be associated with the occurrence of MACE (HR = 4.07 [1.81-9.17], p < 0.001). This result was confirmed after correction for main demographic characteristics such as age, sex and BSA (HR = 2.91 [1.18-7.17], p = 0.020). At penalized Cox regression, age, left atrial dilatation, left ventricular hypertrophy and AAD were identified as best predictor of MACEs and AAD resulted a significant predictor of MACEs even after correction for these confounders (HR = 2.43 [1.02-5.78], p = 0.045). The presence of AAD was found to be associated with an increased risk of MACE independently of for major confounders, including established HMODs. AAD ascending aorta dilatation, LAe left atrial enlargement, LVH left ventricular hypertrophy, MACEs major adverse cardiovascular events, SIIA Società Italiana dell'Ipertensione Arteriosa (Italian Society for Arterial Hypertension).

Indexed as

Aortic DiseasesAtrial FibrillationHypertensionAorta, ThoracicDilatationFemaleFollow-Up StudiesHumansHypertrophy, Left VentricularMaleArterial hypertensionAscending aortaAscending aorta dilatationPrognosisTransthoracic echocardiography

Identifiers

PMID37328694
OpenAlexW4380878389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.